Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
European Journal of Heart Failure|October 25, 2016
Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.European Heart Journal. Quality of Care & Clinical Outcomes|October 13, 2019
The ESC-EORP Chronic Ischaemic Cardiovascular Disease Long Term (CICD LT) registryMichel Komajda, Francesco Cosentino, Roberto Ferrari, et al.American Heart Journal|June 2, 2024
Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50Lee B Bockus, Ramin Shadman, Jeanne E Poole, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2009
Where are we with the management of hypertension? From science to clinical practiceCsaba Farsang, Lisa Naditch-Brule, Angelo Avogaro, et al.European Journal of Heart Failure|June 22, 2013
Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trialNicolas Girerd, Peter S Pang, Karl Swedberg, et al.European Journal of Heart Failure|February 17, 2015
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HFMatthew J Feinstein, Pardeep Jhund, Joseph Kang, et al.European Journal of Heart Failure|October 19, 2010
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trialStefano Ghio, Laura Scelsi, Roberto Latini, et al.American Heart Journal|June 7, 2011
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarctionAnil Verma, Marc A Pfeffer, Hicham Skali, et al.European Heart Journal|June 28, 2007
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trialChristian Torp-Pedersen, Ian Caterson, Walmir Coutinho, et al.European Journal of Heart Failure|December 3, 2010
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)Mihai Gheorghiade, Mazen Albaghdadi, Faiez Zannad, et al.Pageof 8